# Clal Biotechnology

Clal Biotechnology is a Private Equity based in Tel Aviv, Israel.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Tel Aviv, Israel
- **Region:** Middle East
- **Address:** Tel Aviv, Israel
- **Founded:** 1993
- **Assets under management:** Undisclosed
- **Website:** www.cbi.co.il
- **LinkedIn:** https://il.linkedin.com/company/clal-biotechnology-industries

## Regulatory record

- **Reports private funds:** No

## About

Clal Biotechnology Industries (TASE: CBI) is a premier life sciences investment firm listed on the Tel Aviv Stock Exchange. It specializes in identifying and nurturing groundbreaking ventures that develop proprietary solutions to address unmet medical needs with substantial market potential. CBI holds and manages an international portfolio of some thirteen biotechnology companies.

## Sectors

- Venture

## People

- Avi Fischer — CEO
- Arnon Aharon — MD, Medical Director
- Liat Nissan — CFO
- Avi Fischer — Chairman of the Board
- Prof. Gad Keren — Board Member
- Bazil Gamzu — Board Member
- Nufar Malovani — Board Member
- Prof. Gabi Barabash — Board Member
- Tomer Babai — Board Member

## Questions

### What stages does Clal Biotechnology target?

The firm covers seed, start-up, and expansion rounds within its venture and private equity practice.

### Does Clal Biotechnology commit to external funds or make direct investments?

Available records indicate direct investment activity without reference to fund commitments or fund-of-funds structures.

## Related profiles

- [Clairvoyant Ventures](https://altss.com/profile/clairvoyant-ventures)
- [Clal Industries and Investments](https://altss.com/profile/clal-industries-and-investments)

---

Last updated: 2026-08-11T15:06:27.647Z

Canonical page: https://altss.com/profile/clal-biotechnology

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology